Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | KILITCH Kilitch Drugs (India) Limited Pharma · Small | VALIANTLAB Valiant Laboratories Limited Pharma · Small | LYKALABS Lyka Labs Limited Pharma · Small | MEDICO Medico Remedies Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 53 | 15 | 22 | 52 |
| Verdict | FAIR VALUE | OVERVALUED | OVERVALUED | FAIR VALUE |
| Style | Growth at Value | OVERVALUED | OVERVALUED | Financial Turnaround |
| Piotroski | 8/9 | 4/9 | 6/9 | 8/9 |
| Valuation | 14/30 | 3/30 | 5/30 | 8/30 |
| Growth | 22/25 | 2/25 | 6/25 | 14/25 |
| Quality | 1/20 | 0/20 | 0/20 | 14/20 |
| Balance Sheet | 9/15 | 11/15 | 7/15 | 10/15 |
| Cash Flow | 2/10 | 1/10 | 4/10 | 4/10 |
| Price | ₹187.01 | ₹72.82 | ₹70.05 | ₹43.42 |
| P/E | 19.40 | 72.40 | — | 27.60 |
| P/B | 2.09 | 1.25 | 2.46 | 4.80 |
| ROE | 12.50% | 2.00% | -10.20% | 19.00% |
| ROCE | 14.40% | 2.54% | -6.10% | 23.10% |
| Debt / Equity | 0.32 | 0.00 | 0.53 | 0.25 |
| FCF Yield | — | — | — | 0.28% |
| Dividend Y | — | — | — | — |
| Altman Z | 3.72 | 5.48 | 2.96 | 5.25 |
| Promoter % | 14.00% | 74.94% | 58.16% | 61.38% |
| Mkt Cap (₹Cr) | 584.00 | 402.00 | 227.00 | 362.00 |
| Graham # | ₹124.64 | ₹36.77 | — | ₹17.99 |
| Fair PE | 42.0 | 1.7 | 8.7 | 42.0 |
| MoS % | +48.4% | -4074.8% | — | +34.6% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startKILITCH61
VALIANTLAB64
LYKALABS47
MEDICO75